Literature DB >> 16244647

Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations.

J I Patel1, P G Hykin, M Schadt, V Luong, F Fitzke, Z J Gregor.   

Abstract

PURPOSE: A prospective study to evaluate the macular structural and functional effects of pars plana vitrectomy (PPV) for persistent diffuse clinically significant macular oedema (CSMO).
METHOD: A total of 12 patients with persistent diffuse CSMO were recruited and underwent assessment including best-corrected visual acuity, fundus fluorescein angiography, optical coherence tomography (OCT) and fine matrix mapping (FMM) at baseline and over a period of a year poststandard three-port PPV.
RESULTS: The median baseline ETDRS letters score for all 12 patients was 52 (range 41-63) while at 12 months it had increased to 65 (range of 27-68), an improvement of two complete ETDRS lines (P=0.037). Similarly, there was an improvement in the perifoveal cone thresholds (P=0.02). The foveal thickening for all 12 patients ranged from a median of 183 to 751 microm (normal range 126-180 microm) and the macular volume ranged from a median of 2.13 to 6.42 mm(3) (normal <1.66 mm(3)). After surgery, both the median foveal thickness (from 334 to 280 microm) and median macular volume (from 3.24 to 2.61 mm(3)) demonstrated decreases over 12 months (P=0.01). On baseline OCT, the patients fell into two anatomically distinct groups: Group 1 (n=4) had a dome-shaped thickened macula with a partial posterior hyaloid separation and a significantly higher foveal thickness and macular volume than Group 2 (n=8) which had a diffuse low-elevation profile of the thickened macula (P=0.007).
CONCLUSIONS: In this prospective study of PPV for persistent fovea-involving CSMO there was structural and functional improvement.

Entities:  

Mesh:

Year:  2005        PMID: 16244647     DOI: 10.1038/sj.eye.6701945

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  11 in total

1.  Diabetic retinopathy - An update.

Authors:  Abdulrahman A Alghadyan
Journal:  Saudi J Ophthalmol       Date:  2011-01-31

Review 2.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

3.  Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.

Authors:  Matias Iglicki; Catharina Busch; Jay Chhablani; Dinah Zur; Paolo Lanzetta; Valentina Sarao; Daniele Veritti; Nicolò Rassu; Marco Lupidi; Zafer Cebeci; Samantha Fraser-Bell; Carolina Bernal-Morales; Anna Sala-Puigdollers; Javier Zarranz-Ventura; Roberto Gallego-Pinazo; Aniruddha Maiti; Giuseppe D'Amico Ricci; Patricia Udaondo; Anat Loewenstein
Journal:  Eye (Lond)       Date:  2022-01-18       Impact factor: 3.775

Review 4.  Surgical management of diabetic retinopathy.

Authors:  Vishali Gupta; J Fernando Arevalo
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

5.  Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema.

Authors:  Sadık Görkem Çevik; Sami Yılmaz; Mediha Tok Çevik; Fatma Düriye Akalp; Remzi Avcı
Journal:  J Ophthalmol       Date:  2018-04-22       Impact factor: 1.909

6.  Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis.

Authors:  Ozgun Melike Gedar Totuk; Ayse Yagmur Kanra; Mohammed Nadim Bromand; Guler Kilic Tezanlayan; Sevil Ari Yaylalı; Irem Turkmen; Aylin Ardagil Akcakaya
Journal:  J Ophthalmol       Date:  2020-08-06       Impact factor: 1.974

Review 7.  Diabetic retinopathy: an update.

Authors:  Ramandeep Singh; Kim Ramasamy; Chandran Abraham; Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

Review 8.  The diagnostic function of OCT in diabetic maculopathy.

Authors:  Bartosz L Sikorski; Grazyna Malukiewicz; Joanna Stafiej; Hanna Lesiewska-Junk; Dorota Raczynska
Journal:  Mediators Inflamm       Date:  2013-11-28       Impact factor: 4.711

Review 9.  Diabetic macular edema: Evidence-based management.

Authors:  David J Browning; Michael W Stewart; Chong Lee
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

10.  Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study.

Authors:  Matias Iglicki; Alejandro Lavaque; Malgorzata Ozimek; Hermino Pablo Negri; Mali Okada; Jay Chhablani; Catharina Busch; Anat Loewenstein; Dinah Zur
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.